FULC
Price
$7.10
Change
-$0.28 (-3.79%)
Updated
Jun 27 closing price
Capitalization
383.25M
38 days until earnings call
ORMP
Price
$2.15
Change
-$0.02 (-0.92%)
Updated
Jun 27 closing price
Capitalization
87.83M
45 days until earnings call
Interact to see
Advertisement

FULC vs ORMP

Header iconFULC vs ORMP Comparison
Open Charts FULC vs ORMPBanner chart's image
Fulcrum Therapeutics
Price$7.10
Change-$0.28 (-3.79%)
Volume$1.21M
Capitalization383.25M
Oramed Pharmaceuticals
Price$2.15
Change-$0.02 (-0.92%)
Volume$59.11K
Capitalization87.83M
FULC vs ORMP Comparison Chart in %
Loading...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FULC vs. ORMP commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FULC is a Hold and ORMP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (FULC: $7.10 vs. ORMP: $2.15)
Brand notoriety: FULC and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FULC: 185% vs. ORMP: 86%
Market capitalization -- FULC: $383.25M vs. ORMP: $87.83M
FULC [@Biotechnology] is valued at $383.25M. ORMP’s [@Biotechnology] market capitalization is $87.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FULC’s FA Score shows that 1 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • FULC’s FA Score: 1 green, 4 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, FULC is a better buy in the long-term than ORMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FULC’s TA Score shows that 4 TA indicator(s) are bullish while ORMP’s TA Score has 0 bullish TA indicator(s).

  • FULC’s TA Score: 4 bullish, 4 bearish.
  • ORMP’s TA Score: 0 bullish, 8 bearish.
According to our system of comparison, FULC is a better buy in the short-term than ORMP.

Price Growth

FULC (@Biotechnology) experienced а +1.50% price change this week, while ORMP (@Biotechnology) price change was +0.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

FULC is expected to report earnings on Aug 06, 2025.

ORMP is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FULC($383M) has a higher market cap than ORMP($87.8M). FULC YTD gains are higher at: 51.064 vs. ORMP (-11.157). FULC has higher annual earnings (EBITDA): -8.94M vs. ORMP (-21.53M). FULC has more cash in the bank: 227M vs. ORMP (131M). ORMP has less debt than FULC: ORMP (301K) vs FULC (8.11M). FULC has higher revenues than ORMP: FULC (80M) vs ORMP (2M).
FULCORMPFULC / ORMP
Capitalization383M87.8M436%
EBITDA-8.94M-21.53M42%
Gain YTD51.064-11.157-458%
P/E RatioN/A20.91-
Revenue80M2M4,000%
Total Cash227M131M173%
Total Debt8.11M301K2,693%
FUNDAMENTALS RATINGS
FULC vs ORMP: Fundamental Ratings
FULC
ORMP
OUTLOOK RATING
1..100
7416
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
58
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9094
PRICE GROWTH RATING
1..100
3676
P/E GROWTH RATING
1..100
10051
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FULC's Valuation (27) in the null industry is in the same range as ORMP (58) in the Pharmaceuticals Other industry. This means that FULC’s stock grew similarly to ORMP’s over the last 12 months.

FULC's Profit vs Risk Rating (100) in the null industry is in the same range as ORMP (100) in the Pharmaceuticals Other industry. This means that FULC’s stock grew similarly to ORMP’s over the last 12 months.

FULC's SMR Rating (90) in the null industry is in the same range as ORMP (94) in the Pharmaceuticals Other industry. This means that FULC’s stock grew similarly to ORMP’s over the last 12 months.

FULC's Price Growth Rating (36) in the null industry is somewhat better than the same rating for ORMP (76) in the Pharmaceuticals Other industry. This means that FULC’s stock grew somewhat faster than ORMP’s over the last 12 months.

ORMP's P/E Growth Rating (51) in the Pharmaceuticals Other industry is somewhat better than the same rating for FULC (100) in the null industry. This means that ORMP’s stock grew somewhat faster than FULC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FULCORMP
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
73%
Momentum
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 12 days ago
86%
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
85%
Aroon
ODDS (%)
Bullish Trend 3 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KONMY80.951.74
+2.20%
Konami Group Corporation
BREUF10.850.10
+0.93%
Bridgemarq Real Estate Svc Inc.
BRRDF17.40N/A
N/A
Borregaard ASA
BUDFF68.54N/A
N/A
Anheuser Busch Inbev SA NV
PMCCF0.06N/A
N/A
Peloton Minerals Corporation

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with ANNX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then ANNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
-3.79%
ANNX - FULC
40%
Loosely correlated
-1.63%
VRDN - FULC
40%
Loosely correlated
-1.37%
RARE - FULC
39%
Loosely correlated
-2.43%
BMRN - FULC
38%
Loosely correlated
+1.98%
PTGX - FULC
37%
Loosely correlated
+0.86%
More

ORMP and

Correlation & Price change

A.I.dvisor tells us that ORMP and GLSI have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORMP and GLSI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
-0.92%
GLSI - ORMP
29%
Poorly correlated
N/A
FULC - ORMP
28%
Poorly correlated
-3.79%
APLS - ORMP
28%
Poorly correlated
-5.27%
PRLD - ORMP
27%
Poorly correlated
-4.64%
SONN - ORMP
27%
Poorly correlated
-2.61%
More